Theravance (THRX)

Theravance (THRX) Q3 2015 Results - Earnings Call Webcast
Oct. 28, 2015 | Price: Free! | Source: Seeking Alpha

Theravance's (THRX) CEO Michael Aguiar on Q3 2015 Results - Earnings Call Transcript
Oct. 28, 2015 | Price: Free! | Source: Seeking Alpha

Theravance's (THRX) CEO Michael Aguiar on Q2 2015 Results - Earnings Call Transcript
July 29, 2015 | Price: Free! | Source: Seeking Alpha

Theravance's (THRX) CEO Mike Aguiar on Q1 2015 Results - Earnings Call Transcript
May 6, 2015 | Price: Free! | Source: Seeking Alpha

Theravance (THRX) Q1 2015 Results - Earnings Call Webcast
May 6, 2015 | Price: Free! | Source: Seeking Alpha

Theravance (THRX) Q4 2014 Results - Earnings Call Webcast
Feb. 18, 2015 | Price: Free! | Source: Seeking Alpha

Theravance's (THRX) CEO Mike Aguiar on Q4 2014 Results - Earnings Call Transcript
Feb. 18, 2015 | Price: Free! | Source: Seeking Alpha

Theravance's (THRX) CEO Mike Aguiar on Credit Suisse Healthcare Conference - Call Transcript
Nov. 13, 2014 | Price: Free! | Source: Seeking Alpha

Theravance (THRX) Q3 2014 Results - Earnings Call Webcast
Oct. 30, 2014 | Price: Free! | Source: Seeking Alpha

Theravance's (THRX) CEO Mike Aguiar on Q3 2014 Results - Earnings Call Transcript
Oct. 30, 2014 | Price: Free! | Source: Seeking Alpha

Theravance's (THRX) CEO Rick Winningham on Q2 2014 Results - Earnings Call Transcript
Aug. 7, 2014 | Price: Free! | Source: Seeking Alpha

Theravance's (THRX) CEO Rick Winningham Hosts 2014 Annual Meeting of Stockholders Conference
May 22, 2014 | Price: Free! | Source: Seeking Alpha

Theravance's (THRX) CEO Rick Winningham on Bank of America Merrill Lynch 2014 Health Care Conferenc
May 13, 2014 | Price: Free! | Source: Seeking Alpha

Theravance's (THRX) CEO Rick Winningham on Q1 2014 Results - Earnings Call Transcript
May 6, 2014 | Price: Free! | Source: Seeking Alpha

Q1 2014 Theravance Inc Earnings Conference Call (THRX) Q1 2014 Results - Earnings Call Webcast
May 6, 2014 | Price: Free! | Source: Seeking Alpha

Theravance Announces Positive Results From a Phase 2 Study of TD-9855 in Patients With Fibromyalgia
May 1, 2014 | Price: Free! | Source: Seeking Alpha

Theravance's CEO Presents at Barclays Global Healthcare Conference (Transcript)
March 11, 2014 | Price: Free! | Source: Seeking Alpha

Theravance's CEO Discusses Q4 2013 Results - Earnings Call Transcript
Feb. 7, 2014 | Price: Free! | Source: Seeking Alpha

Q4 2013 Theravance Inc Earnings Conference call (Webcast)
Feb. 7, 2014 | Price: Free! | Source: Seeking Alpha

Theravance's Management Presents at 32nd Annual JPMorgan Healthcare Conference (Transcript)
Jan. 16, 2014 | Price: Free! | Source: Seeking Alpha

THERAVANCE INC at Piper Jaffray Healthcare Conference Transcript
Dec. 3, 2013 | Price: $106.00 | Source: Thomson

THERAVANCE INC at Credit Suisse Healthcare Conference Transcript
Nov. 13, 2013 | Price: $106.00 | Source: Thomson

Theravance's CEO Presents at Credit Suisse Healthcare Conference (Transcript)
Nov. 13, 2013 | Price: Free! | Source: Seeking Alpha

Theravance Inc's CEO Discusses Q3 2013 Results - Earnings Call Transcript
Oct. 24, 2013 | Price: Free! | Source: Seeking Alpha

THERAVANCE INC Q3 2013 Earnings Conference Call Transcript
Oct. 24, 2013 | Price: $106.00 | Source: Thomson

THERAVANCE INC at Stifel Nicolaus Weisel Healthcare Conference Transcript
Sept. 12, 2013 | Price: $106.00 | Source: Thomson

THERAVANCE INC at Robert W Baird and Co Health Care Conference Transcript
Sept. 11, 2013 | Price: $106.00 | Source: Thomson

Theravance's CEO Reviews Phase 2b Study 0091 with its LAMA Candidate TD-4208 Results - Transcript
Sept. 5, 2013 | Price: Free! | Source: Seeking Alpha

THERAVANCE INC Conference Call to Discuss Positive Results From TD-4208 for the Treatment of COPD S
Sept. 5, 2013 | Price: $106.00 | Source: Thomson

Theravance Inc (THRX) CEO Discusses Q2 2013 Results - Earnings Call Transcript
July 25, 2013 | Price: Free! | Source: Seeking Alpha

THERAVANCE INC Q2 2013 Earnings Conference Call Transcript
July 25, 2013 | Price: $106.00 | Source: Thomson

THERAVANCE INC at JMP Securities Healthcare Conference Transcript
July 10, 2013 | Price: $106.00 | Source: Thomson

THERAVANCE INC at JMP Securities Healthcare Conference Transcript
July 10, 2013 | Price: $106.00 | Source: Thomson

THERAVANCE INC at Goldman Sachs Healthcare Conference Transcript
June 13, 2013 | Price: $106.00 | Source: Thomson

Theravance's Management Presents at Goldman Sachs Healthcare Conference (Transcript)
June 13, 2013 | Price: Free! | Source: Seeking Alpha

THERAVANCE INC at Jefferies Global Healthcare Conference Transcript
June 5, 2013 | Price: $106.00 | Source: Thomson

THERAVANCE INC at Bank of America Merrill Lynch Health Care Conference Transcript
May 15, 2013 | Price: $106.00 | Source: Thomson

Theravance's CEO Presents at Bank of America Merrill Lynch Health Care Conference (Transcript)
May 15, 2013 | Price: Free! | Source: Seeking Alpha

Theravance and Elan Enter Into a 1 Billion Dollar Royalty Participation Agreement (Transcript)
May 13, 2013 | Price: Free! | Source: Seeking Alpha

Theravance's CEO Discusses Q1 2013 Results - Earnings Call Transcript
April 25, 2013 | Price: Free! | Source: Seeking Alpha

Theravance's CEO Discusses Q1 2013 Results - Earnings Call Transcript
April 25, 2013 | Price: Free! | Source: Seeking Alpha

Theravance's CEO Discusses Q1 2013 Results - Earnings Call Transcript
April 25, 2013 | Price: Free! | Source: Seeking Alpha

Theravance's CEO Discusses Q1 2013 Results - Earnings Call Transcript
April 25, 2013 | Price: Free! | Source: Seeking Alpha

Theravance's CEO Discusses Q1 2013 Results - Earnings Call Transcript
April 25, 2013 | Price: Free! | Source: Seeking Alpha

Theravance's CEO Discusses Q1 2013 Results - Earnings Call Transcript
April 25, 2013 | Price: Free! | Source: Seeking Alpha

THERAVANCE INC Q1 2013 Earnings Conference Call Transcript
April 25, 2013 | Price: $106.00 | Source: Thomson

Theravance's CEO Hosts 2013 Annual Meeting of Stockholders Conference (Transcript)
April 24, 2013 | Price: Free! | Source: Seeking Alpha

THERAVANCE INC at Barclays Healthcare Conference Transcript
March 14, 2013 | Price: $54.00 | Source: Thomson

Theravance Management Presents at Barclays 2013 Global Healthcare Conference (Transcript)
March 14, 2013 | Price: Free! | Source: Seeking Alpha

Theravance's CEO Presents at 2013 Citi Global Healthcare Conference (Transcript)
Feb. 27, 2013 | Price: Free! | Source: Seeking Alpha

Theravance's CEO Discusses Q4 2012 Results - Earnings Call Transcript
Feb. 13, 2013 | Price: Free! | Source: Seeking Alpha

THERAVANCE INC Q4 2012 Earnings Conference Call Transcript
Feb. 12, 2013 | Price: $106.00 | Source: Thomson

THERAVANCE INC at JPMorgan Global Healthcare Conference Transcript
Jan. 9, 2013 | Price: $54.00 | Source: Thomson

Theravance's CEO Presents at J.P. Morgan Global Healthcare Conference (Transcript)
Jan. 9, 2013 | Price: Free! | Source: Seeking Alpha

Theravance's Management Presents at Credit Suisse 2012 Healthcare Conference (Transcript)
Nov. 14, 2012 | Price: Free! | Source: Seeking Alpha

THERAVANCE INC Q3 2012 Earnings Conference Call Transcript
Oct. 30, 2012 | Price: $106.00 | Source: Thomson

Theravance's CEO Discusses Q3 2012 Results - Earnings Call Transcript
Oct. 30, 2012 | Price: Free! | Source: Seeking Alpha

Theravance's Management Present at Morgan Stanley Global Healthcare Conference (Transcript)
Sept. 12, 2012 | Price: Free! | Source: Seeking Alpha

THERAVANCE INC Q2 2012 Earnings Conference Call Transcript
July 31, 2012 | Price: $54.00 | Source: Thomson

Theravance, Inc. CEO Discusses Q2 2012 Earnings Results - Earnings Call Transcript
July 31, 2012 | Price: Free! | Source: Seeking Alpha

Theravance's CEO Announces Positive Topline Results From TD-1211 Phase 2b Study 0084 for the Treatm
July 12, 2012 | Price: Free! | Source: Seeking Alpha

THERAVANCE INC GSK and Theravance Announce Positive Results From Four Pivotal Phase III Studies for
July 2, 2012 | Price: $54.00 | Source: Thomson

Theravance's CEO Discusses LAMA/LABA Phase 3a Results Conference Call (Transcript)
July 2, 2012 | Price: Free! | Source: Seeking Alpha

THERAVANCE INC at Bank of America Merrill Lynch Smid Cap Conference Transcript
June 7, 2012 | Price: $54.00 | Source: Thomson

THERAVANCE INC Q1 2012 Earnings Conference Call Transcript
April 26, 2012 | Price: $54.00 | Source: Thomson

Theravance, Inc.(THRX) Q1 2012 Earnings Call Transcript
April 26, 2012 | Price: Free! | Source: Morningstar

Theravance Inc. CEO Discusses Q3 2010 Results - Earnings Call Transcript
Oct. 21, 2010 | Price: Free! | Source: Seeking Alpha

Theravance Inc Q2 2010 Earnings Call Transcript
July 22, 2010 | Price: Free! | Source: Seeking Alpha

Theravance Inc. Q1 2010 Earnings Call Transcript
April 21, 2010 | Price: Free! | Source: Seeking Alpha

Theravance, Inc. Q3 2009 Earnings Call Transcript
Oct. 27, 2009 | Price: Free! | Source: Seeking Alpha

Theravance, Inc. Q4 2008 Earnings Call Transcript
Feb. 12, 2009 | Price: Free! | Source: Seeking Alpha

Theravance, Inc. Q3 2008 Earnings Call Transcript
Oct. 29, 2008 | Price: Free! | Source: Seeking Alpha

Theravance, Inc. Q2 2008 Earnings Call Transcript
Aug. 11, 2008 | Price: Free! | Source: Seeking Alpha

Recent filings

Theravance: Innoviva Names Geoffrey Hulme As Interim Principal Executive Officer - May 23, 2018

Theravance's interim PEO just declared owning 3,500 shares of Theravance - May 22, 2018

Theravance's SVP and CFO just disposed of 13,709 shares - May 22, 2018

Theravance's Sr. VP & Chief Comm. Officer just disposed of 12,682 shares - May 22, 2018

Theravance's Sr. VP & Chief Scientific Off. just disposed of 3,089 shares - May 22, 2018

Theravance Just Filed Its Quarterly Report:   2. Net Income... - May 4, 2018

Theravance director just picked up 14,249 shares - April 26, 2018

Theravance director just picked up 14,249 shares - April 26, 2018

Theravance director just picked up 14,249 shares - April 26, 2018

Theravance: Innoviva Reports First Quarter 2018 Financial Results - April 26, 2018

Theravance director just picked up 14,249 shares - April 26, 2018

Theravance director just picked up 14,249 shares - April 26, 2018

Theravance: April 24, 2018, London Uk — Lse Announcement - April 24, 2018

General statement of acquisition of beneficial ownership - April 10, 2018

Theravance releases salary data. CEO sees compensation rise 16% - March 23, 2018

Theravance Just Filed Its Annual Report:                  ... - Feb. 23, 2018

Theravance's Sr. VP & Chief Comm. Officer just disposed of 23,500 shares - Feb. 22, 2018

Theravance's Sr. VP & Chief Scientific Off. just disposed of 26,590 shares - Feb. 22, 2018

Interim PEO of Theravance just disposed of 30,254 shares - Feb. 22, 2018

Theravance director just picked up 10,517 shares - Feb. 14, 2018

Statement of acquisition of beneficial ownership by individuals - Feb. 13, 2018

Theravance: Innoviva Reports Record Fourth Quarter And Full Year 2017 Financial Results - Feb. 8, 2018

BlackRock, Inc. just provided an update on share ownership of Theravance - Feb. 8, 2018

Departure of Directors or Certain - Feb. 7, 2018

Theravance: 26 January 2018 London Uk And Brisbane, Calif. — Lse Announcement - Jan. 26, 2018

Amendments to Articles of Incorporation or - Jan. 10, 2018

Regulation FD - Dec. 22, 2017

Theravance director just declared 0 ownership of the company. - Dec. 21, 2017

Theravance director just picked up 14,513 shares - Dec. 21, 2017

Theravance director just declared 0 ownership of the company. - Dec. 21, 2017

Theravance director just picked up 14,513 shares - Dec. 21, 2017

Theravance: Innoviva And Sarissa Implement Court Order - Dec. 20, 2017

Regulation FD - Dec. 11, 2017

Theravance's President & Chief Exec Officer just disposed of 12,022 shares - Dec. 5, 2017

Theravance's Sr. VP & Chief Scientific Off. just disposed of 27,757 shares - Nov. 22, 2017

Theravance's President & Chief Exec Officer just disposed of 43,038 shares - Nov. 22, 2017

Theravance's Sr VP & Chief Business Officer just disposed of 4,470 shares - Nov. 22, 2017

Theravance's SVP and CFO just disposed of 21,426 shares - Nov. 22, 2017

Theravance's Sr. VP & Chief Comm. Officer just disposed of 8,573 shares - Nov. 22, 2017

Theravance: Innoviva Reports Third Quarter 2017 Financial Results And Provides Business Updates - Oct. 25, 2017

Theravance: 19 September 2017, London Uk - Sept. 20, 2017

Theravance: 18 September 2017, London Uk — Lse Announcement - Sept. 19, 2017

Theravance: 15 September 2017, London Uk — Lse Announcement - Sept. 15, 2017

Theravance's Sr. VP & Chief Scientific Off. just disposed of 2,596 shares - Aug. 22, 2017

Theravance's President & Chief Exec Officer just disposed of 12,917 shares - Aug. 22, 2017

Theravance's Sr VP & Chief Business Officer just disposed of 3,179 shares - Aug. 22, 2017

Theravance's SVP and CFO just disposed of 7,595 shares - Aug. 22, 2017

Theravance's Sr. VP & Chief Comm. Officer just disposed of 2,886 shares - Aug. 22, 2017

Theravance: Innoviva Completes Refinancing Of Its 9% 2029 Non-Recourse Notes - Aug. 21, 2017

Report of proposed sale of securities - Aug. 10, 2017

Theravance Just Filed Its Quarterly Report:   ... - Aug. 8, 2017

Theravance: Innoviva, Inc. Announces Closing Of $175 Million Offering Of 2.50% Convertible Senior Notes And Exercise Of The Initial Purchasers’ $17.5 Million Over-Allotment Option - Aug. 7, 2017

Theravance: Innoviva, Inc. Prices Offering Of $175 Million Of 2.50% Convertible Senior Notes - Aug. 2, 2017

Theravance: Innoviva Announces Proposed Offering Of $175 Million Of Convertible Senior Notes - Aug. 1, 2017

Theravance: Innoviva Reports Strong Second Quarter 2017 Financial Results - July 26, 2017

Submission of Matters to a Vote of Security - July 21, 2017

Departure of Directors or Certain - June 2, 2017

Theravance's President & Chief Exec Officer just disposed of 12,897 shares - May 23, 2017

Theravance's Sr. VP & Chief Comm. Officer just disposed of 2,228 shares - May 23, 2017

Theravance's Sr VP & Chief Business Officer just disposed of 3,176 shares - May 23, 2017

Theravance's Sr. VP & Chief Scientific Off. just disposed of 10,405 shares - May 23, 2017

Theravance's SVP and CFO just disposed of 6,033 shares - May 23, 2017

Seth A. Klarman just provided an update on share ownership of Theravance - May 9, 2017

Theravance: Eric Dube, Senior Vice President And Head, Global Respiratory Franchise Gsk, Said - May 5, 2017

Theravance: In The Court Of Chancery Of The State Of Delaware SARISSA CAPITAL DOMESTIC FUND LP, SARISSA OFFSHORE MASTER FUND LP, SARISSA CAPITAL FUND GP LLC, SARISSA CAPITAL FUND GP LP, SARISSA CA - May 2, 2017

Submission of Matters to a Vote of Security - April 28, 2017

Submission of Matters to a Vote of Security - April 26, 2017

Theravance director just picked up 19,857 shares - April 24, 2017

Theravance director just picked up 19,857 shares - April 24, 2017

Theravance director just picked up 19,857 shares - April 24, 2017

Theravance director just picked up 19,857 shares - April 24, 2017

Theravance director just picked up 19,857 shares - April 24, 2017

Theravance director just picked up 19,857 shares - April 24, 2017

Theravance: Soliciting Material Under §240.14A-12 INNOVIVA, INC. - April 20, 2017

Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material - April 20, 2017

Theravance: Soliciting Material Under §240.14A-12 INNOVIVA, INC. - April 19, 2017

Theravance: Soliciting Material Under §240.14A-12 INNOVIVA, INC. - April 18, 2017

Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material - April 18, 2017

Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material - April 17, 2017

Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material - April 17, 2017

Theravance: Soliciting Material Under §240.14A-12 INNOVIVA, INC. - April 17, 2017

Theravance: Soliciting Material Under §240.14A-12 INNOVIVA, INC. - April 14, 2017

Theravance: Soliciting Material Under §240.14A-12 INNOVIVA, INC. - April 13, 2017

Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material - April 13, 2017

GlaxoSmithKline plc just provided an update on activist position in Theravance - April 13, 2017

Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material - April 12, 2017

Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material - April 12, 2017

Theravance: Soliciting Material Under §240.14A-12 INNOVIVA, INC. - April 12, 2017

Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material - April 12, 2017

Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material - April 11, 2017

Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material - April 10, 2017

Theravance: Soliciting Material Under §240.14A-12 INNOVIVA, INC. - April 10, 2017

Theravance: Innoviva Announces $50 Million Partial Royalty Notes Redemption - April 10, 2017

Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material - April 10, 2017

Theravance: Soliciting Material Under §240.14A-12 INNOVIVA, INC. - April 7, 2017

Confidential treatment order - April 6, 2017

Confidential treatment order - April 6, 2017

Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material - April 6, 2017

. Iridian Asset Management LLC just provided an update on share ownership of Theravance - April 4, 2017

Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material - April 4, 2017

Sorry, no schedule available for this company

Owner Shares% of PortfolioAs Of
1. BlackRock, Inc. 7,038,451 N/A Jan. 22, 2016
2. GLG Partners LP 4,000,000 0.2 June 30, 2017
3. WELLS FARGO & COMPANY/MN 276,000 N/A Sept. 30, 2016
4. Alden Global Capital Ltd 195,700 N/A Dec. 31, 2014
5. Absolute Return Capital, LLC 92,765 N/A Sept. 30, 2015
6. Adamant Biomedical Investments AG 35,000 N/A Dec. 31, 2014
7. Russell Frank Co/ 7,374 N/A Sept. 30, 2015

Theravance (THRX)

140
 


Feedback